Pharmacological inhibition of Hippo pathway with XMU-MP-1 does not improve outcomes in mice with autoimmune myocarditis.

Back

HFA Premium Access

Pharmacological inhibition of Hippo pathway with XMU-MP-1 does not improve outcomes in mice with autoimmune myocarditis.

Session: Heart Failure ePosters - focus on Chronic Heart Failure 6

Topic: Experimental Heart Failure

Speaker: Doctor M. Nieto (Valladolid, ES)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Marisa Nieto

Centre for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Valladolid (Spain)

0 follower

34 more presentations in this session

Prospective evaluation of left heart echocardiographic parameters of the EMPAG-HF patient cohort(effects of empagliflozin on diuresis and renal function in patients with acute decompensated HF)

Speaker: Mr J. Bogoviku (Jena, DE)

Access

Abstract

Slides

T cell and antibody response following double dose of BNT162b2 mRNA Vaccine in heart transplant recipients

Speaker: Doctor M. Vanderheyden (Aalst, BE)

Access

Abstract

Slides

Device-detected sleep-disordered breathing predicts implantable defibrillator therapy in patients with heart failure.

Speaker: Doctor A. Mazza (Orvieto, IT)

Access

Abstract

Slides

A preliminary evaluation of a novel lifestyle intervention in patients with hypertrophic cardiomyopathy

Speaker: Miss A. Fuller (Newcastle-Upon-Tyne, GB)

Access

Abstract

Slides

Recovery of left ventricular dysfunction after sacubitril/valsartan administration in patients with Duchenne muscular distrophy and advanced heart failure

Speaker: Doctor A. Arcudi (Rome, IT)

Access

Abstract

Slides

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 6

Speakers: Doctor M. Nieto, Mr J. Bogoviku, Doctor M. Vanderheyden, Doctor A. Mazza, Miss A. Fuller...

Access

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources